B01 - Notice of Intent - W81XWH21C0091.docx

NOTICE OF INTENT

The U.S. Army Medical Research Acquisition Activity (USAMRAA) intends award on a sole source basis a modification to existing contract W81XWH21C0091 on behalf of The U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID). Contract W81XWH21C0091 was awarded to Getinge USA Sales, LLC. on 01 July 2021. This requirement is to execute the passivation of thirty-eight (38) existing Getinge autoclaves currently installed onsite and connected to the effluent decontamination plumbing lines within the existing building. This process includes disassembly, prepping, reassembly, and testing. Getinge USA Sales, LLC is the sole provider capable of executing the passivation process in its entirety and coordinating a long-term storage solution that will allow future upgrade and testing of the autoclaves in USAMRIID II. Getinge USA Sales, LLC is the Original Equipment Manufacturer (OEM) authorized dealer, distributor and/or reseller for the autoclaves such that OEM service is provided and maintained by the OEM. All software licensing, warranty and service associated with the equipment shall be in accordance with the OEM terms and conditions.

This announcement fulfills the synopsis requirements under FAR 5.2. This notice of intent is NOT a request for quotations (RFQ) and no solicitation document exists for the requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail and with convincing evidence that clearly demonstrates the capability to provide these supplies. A determination by the Government not to compete this proposed contract action based upon responses to this notice is solely within the discretion of the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source procurement.

Capability statements are due no later than 1300 Eastern Time, 05 September 2024. Capability statements shall be submitted via email ONLY as a Microsoft Word or Adobe PDF attachment to the following email address deborah.l.hagan.civ@health.mil and tonya.r.kreps.civ@health.mil No phone calls will be accepted.